(Q30703991)

26 June 2017

Do national medicinal drug policies and essential drug programs improve drug use?: a review of experiences in developing countries (English)

1 reference

26 June 2017

Ratanawijitrasin S

1

1 reference

26 June 2017

Soumerai SB

series ordinal

2

1 reference

26 June 2017

Weerasuriya K

series ordinal

3

1 reference

26 June 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

Social Science and Medicine

26 June 2017

1 reference

26 June 2017

53

1 reference

26 June 2017

831-844

1 reference

26 June 2017

7

1 reference

Assessing the impact of a regulatory intervention in Pakistan

26 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900390-7

7 January 2021

Lessons from international experience in controlling pharmaceutical expenditure. III: Regulating industry

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900390-7

7 January 2021

Effect of a drug supply and cost sharing system on prescribing and utilization: a controlled trial from Nepal

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900390-7

7 January 2021

A national program for control of acute respiratory tract infections: the Philippine experience

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900390-7

7 January 2021

Effect of diarrhoeal disease control on infant and childhood mortality in Egypt. Report from the National Control of Diarrheal Diseases Project

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900390-7

7 January 2021

Impact of an essential drugs programme on availability and rational use of drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900390-7

7 January 2021

Use and Abuse of Benzodiazepines in Hong Kong 1990–1993 – The Impact of Regulatory Changes

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900390-7

7 January 2021

A strategy for promoting improved pharmaceutical use: the International Network for Rational Use of Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900390-7

7 January 2021

Effects of a limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900390-7

7 January 2021

A critical analysis of studies of state drug reimbursement policies: research in need of discipline

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900390-7

7 January 2021

Evaluation of rational drug prescribing in Democratic Yemen

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900390-7

7 January 2021

Sri Lanka: The Impact of Allowing Paramedical Prescription and Resupply of Oral Contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900390-7

7 January 2021

10.1016/S0277-9536(00)00390-7

Identifiers

DOI

1 reference

26 June 2017

1 reference